ノースカロライナにおける皮膚筋炎の臨床試験
ノースカロライナ内の拠点で、皮膚筋炎に関する8件の研究が参加者を募集しています。
ノースカロライナ内の都市
公式研究テキスト（英語）
Environmental Risk Factors for the Anti-synthetase Syndrome
- NIEHS Clinical Research Unit (CRU), Research Triangle Park
被験者募集中観察研究健康なボランティア歓迎
2歳〜100歳 · 全性別 · 2026/09/28更新 · NCT01276470A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Research Site, Charlotte
- Research Site, Durham
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/09/24更新 · NCT06455449Adult and Juvenile Myositis
- NIEHS Clinical Research Unit (CRU), Research Triangle Park
被験者募集中観察研究健康なボランティア歓迎
2歳〜100歳 · 全性別 · 2026/09/24更新 · NCT00017914RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- University of North Carolina at Chapel Hill - Accepting Adult Patients, Chapel Hill
- Duke University Medical Center - Accepting Young Adults and Juvenile Patients, Durham
被験者募集中第2/3相
6歳〜75歳 · 全性別 · 2026/09/17更新 · NCT06154252A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Research Site, Chapel Hill
被験者募集中第1相
18歳〜70歳 · 全性別 · 2026/09/15更新 · NCT06916806A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Atrium Health Rheumatology-Southpark, Charlotte
- Duke University Medical Center, Durham
被験者募集中第1相
18歳〜74歳 · 全性別 · 2026/09/10更新 · NCT07085104Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- Universtity of North Carolina at Chapel Hill, Chapel Hill
被験者募集中第1相
18歳〜85歳 · 全性別 · 2026/07/22更新 · NCT06371417A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- Duke University, Durham
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/14更新 · NCT07115745ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。